Teva Pharmaceutical Industries Limited (TEVA) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -40M | 1.16B | 369M | 227M | -105M | 575M | 693M | 103M | -124M | 1.18B | 5M | 324M |
| Operating CF Margin % | -1% | 24.58% | 8.24% | 5.44% | -2.7% | 13.6% | 16% | 2.47% | -3.25% | 26.57% | 0.13% | 8.35% |
| Operating CF Growth % | 61.9% | 101.39% | -46.75% | 120.39% | 15.32% | -51.44% | 13760% | -68.21% | 14.48% | 21.69% | -99.08% | 163.41% |
| Net Income | 369M | 481M | 434M | 283M | 220M | -275M | -390M | -874M | -419M | 433M | 88M | -898M |
| Depreciation & Amortization | 239M | 260M | 249M | 251M | 244M | 269M | 259M | 259M | 272M | 266M | 283M | 300M |
| Stock-Based Compensation | 43M | 51M | 34M | 38M | 34M | 34M | 29M | 32M | 28M | 28M | 31M | 30M |
| Deferred Taxes | 0 | -595M | 107M | -211M | 28M | 32M | -53M | -424M | -189M | 32M | -199M | -44M |
| Other Non-Cash Items | -691M | 732M | 106M | 202M | 69M | 760M | 531M | 1.12B | 681M | 99M | 40M | 732M |
| Working Capital Changes | 0 | 229M | -561M | -336M | -700M | -245M | 317M | -10M | -497M | 326M | -238M | 204M |
| Change in Receivables | 354M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 362M | 371M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | 229M | 165M | 135M | 236M | 201M | 202M | 268M | 178M | 144M | 301M | 184M | 302M |
| Capital Expenditures | -168M | -142M | -136M | -96M | -127M | -129M | -148M | -97M | -124M | -119M | -149M | -119M |
| CapEx % of Revenue | 4.22% | 3.01% | 3.04% | 2.3% | 3.26% | 3.05% | 3.42% | 2.33% | 3.25% | 2.67% | 3.87% | 3.07% |
| Acquisitions | 0 | 0 | 8M | 9M | 17M | 4M | 38M | 1M | -15M | 0 | 10M | 56M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 397M | 282M | 276M | 339M | 322M | 342M | 339M | 317M | 295M | 422M | 371M | -4M |
| Cash from Financing | 13M | 40M | -453M | 6M | -1.74B | -674M | 0 | -966M | -151M | -576M | -576M | -55M |
| Debt Issued (Net) | -45.88M | -1.36M | -451M | 5M | -1.37B | -685M | 0 | -956M | 0 | -500M | -500M | 0 |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 58.88M | 41.36M | -2M | 1M | -376M | 11M | 0 | -10M | -151M | -76M | -76M | -55M |
| Net Change in Cash | 185M | 1.35B | 42M | 464M | -1.6B | -19M | 1.06B | -733M | -236M | 977M | -420M | 494M |
| Free Cash Flow | -208M | 1.02B | 233M | 131M | -232M | 446M | 545M | 6M | -248M | 1.06B | -144M | 205M |
| FCF Margin % | -5.22% | 21.57% | 5.2% | 3.14% | -5.96% | 10.55% | 12.58% | 0.14% | -6.49% | 23.89% | -3.74% | 5.29% |
| FCF Growth % | 10.34% | 127.8% | -57.25% | 2083.33% | 6.45% | -58.12% | 478.47% | -97.07% | 12.68% | 28.16% | -134.2% | 5225% |
| FCF per Share | -0.18 | 0.87 | 0.20 | 0.11 | -0.20 | 0.39 | 0.48 | 0.01 | -0.22 | 0.94 | -0.13 | 0.18 |
| FCF Conversion (FCF/Net Income) | -0.11x | 2.41x | 0.85x | 0.80x | -0.49x | -2.65x | -1.59x | -0.12x | 0.89x | 2.56x | 0.07x | -0.37x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |